CIK: 1678984 - Address: C/O Crinetics Pharmaceuticals, Inc., 6055 Lusk Boulevard, San Diego, CA 92121
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/19/24 18:44
3/18/24
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS-475.040-9-5193D
7/5/23 21:11
7/3/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS-4325.040-2-280D
6/5/23 18:06
6/1/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS.m-9830.640-3-481D
5/16/23 20:29
5/15/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS-73934.550-21-2084D
5/2/23 16:01
5/1/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS-10131.700-3-563D
4/4/23 16:24
4/3/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS-10332.150-3-566D
3/9/23 21:46
3/9/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS-58531.590-19-2073D
3/2/23 21:25
3/1/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS-10733.500-3-649D
2/2/23 21:38
2/1/23
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSchilke TobinTNOCFOS.d-11134.600-3-655D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact